<p><b>A.</b> Conversion of FRET substrates by SVV-001 3C<sup>pro</sup> produced by a cellular SVV infection of permissive SCLC line, NCI-H446. Data points represent the average of three replicates at each time point. The L/VP4.1 FP substrate incubated with uninfected and infected cells, using similar incubations of NHL FP substrate as a negative control. Lines of the same color correspond to curve fits from GraphPad. Error bars on data points were removed for figure clarity. <b>B.</b> Initial reaction rates of L/VP4.1 peptide cleavage by recombinant SVV-001 3C<sup>pro</sup>. Data points represent the initial rate of reaction at each concentration of L/VP4.1 peptide calculated from three replicate experiments. Data points were fit to a Micha...
(A) A multi-step viral growth curve was performed. siSCRAMBLE or siTBK1 cells were infected with an ...
<p>(A) Stains-All staining of DSP-PP<sub>240</sub> cleavage. Lane 1: CM<sub>0–3d</sub> of virus-infe...
<p>Panel A shows the overall structure of the recombinant protein substrates used for analysis. In t...
<p>Alignment of SVV L/VP4 cleavage site (shown in italics) with L/VP4 junction sequences of closely ...
The oncolytic picornavirus Seneca Valley Virus (SVV-001) demonstrates anti-tumor activity in models ...
<p>Panels A and B show an analysis of the P1´and P2´specificities. The sequences of the different su...
<p>CM<sub>3–7d</sub> from virus infected cells (containing most intact DSP-PP<sub>240</sub>), was mi...
<p>Solid and broken lines indicate the growth curves of SAFV-3 on HeLa-N and HeLa-R cells, respectiv...
<p>(A) Workflow of HPG pulse-labeling for the earliest analysis of translation during single-step re...
Processing of the human immunodeficiency virus type 1 (HIV-1) Gag and Gag-Pro-Pol polyproteins by th...
<p>(A) Binding of Alexa Fluor 488-conjugated TSPyV VP1 pentamers to mock (PBS) or with 1 U/ml <i>Clo...
(A) HeLa cells were mock- or HRV16-infected (MOI 10), cell lysates were generated at the indicated t...
<p>A) The CPE on MDCK cells infected with SH37T (1∶10 diluted) at 24, 48, and 72 hours post-infectio...
<p><b>(A)</b> Flow chart of the approach taken to identify putative substrates for TvROM1 using quan...
<p>SVV infects a fraction of tumor cells (1), producing 3C<sup>pro</sup> during the viral life cycle...
(A) A multi-step viral growth curve was performed. siSCRAMBLE or siTBK1 cells were infected with an ...
<p>(A) Stains-All staining of DSP-PP<sub>240</sub> cleavage. Lane 1: CM<sub>0–3d</sub> of virus-infe...
<p>Panel A shows the overall structure of the recombinant protein substrates used for analysis. In t...
<p>Alignment of SVV L/VP4 cleavage site (shown in italics) with L/VP4 junction sequences of closely ...
The oncolytic picornavirus Seneca Valley Virus (SVV-001) demonstrates anti-tumor activity in models ...
<p>Panels A and B show an analysis of the P1´and P2´specificities. The sequences of the different su...
<p>CM<sub>3–7d</sub> from virus infected cells (containing most intact DSP-PP<sub>240</sub>), was mi...
<p>Solid and broken lines indicate the growth curves of SAFV-3 on HeLa-N and HeLa-R cells, respectiv...
<p>(A) Workflow of HPG pulse-labeling for the earliest analysis of translation during single-step re...
Processing of the human immunodeficiency virus type 1 (HIV-1) Gag and Gag-Pro-Pol polyproteins by th...
<p>(A) Binding of Alexa Fluor 488-conjugated TSPyV VP1 pentamers to mock (PBS) or with 1 U/ml <i>Clo...
(A) HeLa cells were mock- or HRV16-infected (MOI 10), cell lysates were generated at the indicated t...
<p>A) The CPE on MDCK cells infected with SH37T (1∶10 diluted) at 24, 48, and 72 hours post-infectio...
<p><b>(A)</b> Flow chart of the approach taken to identify putative substrates for TvROM1 using quan...
<p>SVV infects a fraction of tumor cells (1), producing 3C<sup>pro</sup> during the viral life cycle...
(A) A multi-step viral growth curve was performed. siSCRAMBLE or siTBK1 cells were infected with an ...
<p>(A) Stains-All staining of DSP-PP<sub>240</sub> cleavage. Lane 1: CM<sub>0–3d</sub> of virus-infe...
<p>Panel A shows the overall structure of the recombinant protein substrates used for analysis. In t...